Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Therapeutic advance in progressive multiple sclerosis (MS) has been very slow. Based on the transformative role magnetic resonance imaging (MRI) contrast-enhancing lesions had on drug development for relapsing-remitting MS, we consider the lack of sensitive outcomes to be the greatest barrier for de...

Full description

Saved in:
Bibliographic Details
Published in:Front Neurol
Main Authors: Kosa, Peter, Ghazali, Danish, Tanigawa, Makoto, Barbour, Chris, Cortese, Irene, Kelley, William, Snyder, Blake, Ohayon, Joan, Fenton, Kaylan, Lehky, Tanya, Wu, Tianxia, Greenwood, Mark, Nair, Govind, Bielekova, Bibiana
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2016
Subjects:
Neuroscience
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4983704/
https://ncbi.nlm.nih.gov/pubmed/27574516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2016.00131
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items